Table 4.
Palmitate and oleate enrichments in the morning and afternoon biopsy in both males and females
| Males |
Females |
|||
|---|---|---|---|---|
| Morning | Afternoon | Morning | Afternoon | |
| Plasma free fatty acid 13C enrichment, MPE | ||||
| Oleate | 0.182 ± 0.021 (n = 21) | 0.196 ± 0.024 (n = 20) | ||
| imTG-fatty acid 13C enrichment, MPE | ||||
| Palmitate | 0.021 ± 0.002 (n = 20) | 0.020 ± 0.001 (n = 20) | 0.017 ± 0.002 (n = 21) | 0.015 ± 0.002 (n = 21) |
| Oleate | 0.010 ± 0.000** (n = 20) | 0.012 ± 0.001 (n = 20) | 0.008 ± 0.001* (n = 19) | 0.009 ± 0.001 (n = 19) |
| im Long chain acyl-carnitine fatty acid 13C enrichment, MPE | ||||
| Palmitoyl | 0.016 ± 0.002 (n = 20) | 0.017 ± 0.002 (n = 20) | 0.014 ± 0.002 (n = 19) | 0.015 ± 0.003 (n = 19) |
| Oleoyl | 0.001 ± 0.001* (n = 20) | 0.002 ± 0.001 (n = 20) | 0.001 ± 0.000* (n = 19) | 0.002 ± 0.001 (n = 19) |
| imNEFA fatty acid 13C enrichment, MPE | ||||
| Palmitate | 0.020 ± 0.003* (n = 13) | 0.018 ± 0.002 (n = 13) | 0.022 ± 0.002* (n = 19) | 0.020 ± 0.002 (n = 19) |
| Oleate | 0.008 ± 0.001** (n = 13) | 0.012 ± 0.002 (n = 13) | 0.005 ± 0.001** (n = 19) | 0.008 ± 0.002 (n = 19) |
Values are means ± SE; n, no. of subjects. The plasma oleate enrichments are those from the final 30 min of the insulin clamp. MPE, moles percent enrichment; im, intramyocellular.
P < 0.05 between A.M. and P.M. sample;
P < 0.01 between morning and afternoon samples.